COVID-19 Risk Factors for Cancer Patients: A First Report with Comparator Data from COVID-19 Negative Cancer Patients.

Cancers (Basel) · 2021 · PMC8161328 · PMID 34069565

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

When compared to solid malignancies, those with hematological malignancies were at a significantly increased risk of mild/moderate (OR = 2.30, 95%CI:1.38–3.83) and severe COVID-19 (OR = 2.43, 95%CI:1.00–5.90), though the latter was borderline significant.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.